Levofloxacin in vitro activities bacteremic isolates of Streptococcus pneumoniae

被引：20

作者：

Plouffe, JF

Baird, I

Barnishan, J

PorterfieldBaxa, J

Best, M

Dalieh, S

Emerick, J

Fass, RJ

Gianakopoulos, G

Hackman, BA

Hadley, S

Herbert, M

Koletar, SL

Maher, W

Minor, JA

Oglevee, BA

Para, MF

Parsons, J

Rogers, T

ScottTibbs, G

Tumbleson, CS

机构：

[1] Department of Internal Medicine, Ohio State University, Columbus, OH

[2] N-1135 Doan Hall, OSU Medical Center, Columbus

来源：

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 1996年 / 25卷 / 01期

关键词：

D O I：

10.1016/0732-8893(96)00068-5

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Levofloxacin had excellent activity in vitro against bacteremic isolates of Streptococcus pneumoniae with 495 (99.2%) of 499 isolates being susceptible. A total of 38 (97.4%) of 39 isolates with minimal inhibitory concentrations greater than or equal to 0.12 mu g/ml of penicillin were susceptible to levofloxacin. There tons excellent correlation between the disk diffusion and broth microdilution methods for determining susceptibility. Resistant isolates be longed to four different serotypes. There was no increase in proportion of isolates of S. pneumoniae resistant between 1991 and 1994.

引用

收藏

页码：43 / 45

页数：3

相关论文

共 20 条

[1] WORLDWIDE DEVELOPMENT OF ANTIBIOTIC-RESISTANCE IN PNEUMOCOCCI [J].

APPELBAUM, PC .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1987, 6 (04) :367-377

[2] PNEUMOCOCCAL BACTEREMIA IN MONROE COUNTY, NEW-YORK [J].

BENNETT, NM ;

BUFFINGTON, J ;

LAFORCE, FM .

AMERICAN JOURNAL OF PUBLIC HEALTH, 1992, 82 (11) :1513-1516

[3] PNEUMOCOCCAL BACTEREMIA IN CHARLESTON COUNTY, SOUTH-CAROLINA - A DECADE LATER [J].

BREIMAN, RF ;

SPIKA, JS ;

NAVARRO, VJ ;

DARDEN, PM ;

DARBY, CP .

ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (07) :1401-1405

[4] EMERGENCE OF DRUG-RESISTANT PNEUMOCOCCAL INFECTIONS IN THE UNITED-STATES [J].

BREIMAN, RF ;

BUTLER, JC ;

TENOVER, FC ;

ELLIOTT, JA ;

FACKLAM, RR .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (23) :1831-1835

[5]

BROOME CV, 1981, REV INFECT DIS, V3, P277

[6] NEW AND EMERGING ETIOLOGIES FOR COMMUNITY-ACQUIRED PNEUMONIA WITH IMPLICATIONS FOR THERAPY - A PROSPECTIVE MULTICENTER STUDY OF 359 CASES [J].

FANG, GD ;

FINE, M ;

ORLOFF, J ;

ARISUMI, D ;

YU, VL ;

KAPOOR, W ;

GRAYSTON, JT ;

WANG, SP ;

KOHLER, R ;

MUDER, RR ;

YEE, YC ;

RIHS, JD ;

VICKERS, RM .

MEDICINE, 1990, 69 (05) :307-316

[7] INVITRO AND INVIVO ANTIBACTERIAL ACTIVITIES OF LEVOFLOXACIN (L-OFLOXACIN), AN OPTICALLY-ACTIVE OFLOXACIN [J].

FU, KP ;

LAFREDO, SC ;

FOLENO, B ;

ISAACSON, DM ;

BARRETT, JF ;

TOBIA, AJ ;

ROSENTHALE, ME .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (04) :860-866

[8] THE PREVALENCE OF DRUG-RESISTANT STREPTOCOCCUS-PNEUMONIAE IN ATLANTA [J].

HOFMANN, J ;

CETRON, M ;

FARLEY, MM ;

BAUGHMAN, WS ;

FACKLAM, RR ;

ELLIOTT, JA ;

DEAVER, KA ;

BREIMAN, RF .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (08) :481-486

[9] SEROTYPES OF RESPIRATORY ISOLATES OF STREPTOCOCCUS-PNEUMONIAE COMPARED WITH THE CAPSULAR TYPES INCLUDED IN THE CURRENT PNEUMOCOCCAL VACCINE [J].

JORGENSEN, JH ;

HOWELL, AW ;

MAHER, LA ;

FACKLAM, RR .

JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (03) :644-646

[10] PNEUMOCOCCAL RESISTANCE TO ANTIBIOTICS [J].

KLUGMAN, KP .

CLINICAL MICROBIOLOGY REVIEWS, 1990, 3 (02) :171-196